A novel nano-iron supplement versus standard treatment for iron deficiency anaemia in children 6–35 months (IHAT-GUT trial): a double-blind, randomised, placebo-controlled non-inferiority phase II trial in The GambiaResearch in context

A novel nano-iron supplement versus standard treatment for iron deficiency anaemia in children 6–35 months (IHAT-GUT trial): a double-blind, randomised, placebo-controlled non-inferiority phase II trial in The GambiaResearch in context

Summary: Background: Iron deficiency anaemia (IDA) is the leading cause of years lost to disability in most sub-Saharan African countries and is especially common in young children. The IHAT-GUT trial assessed the efficacy and safety of a novel nano iron supplement, which is a dietary ferritin anal...

Full description

Bibliographic Details
Main Authors: Nuredin I. Mohammed, James Wason, Thomas Mendy, Stefan A. Nass, Ogochukwu Ofordile, Famalang Camara, Bakary Baldeh, Chilel Sanyang, Amadou T. Jallow, Ilias Hossain, Nuno Faria, Jonathan J. Powell, Andrew M. Prentice, Dora I.A. Pereira
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:EClinicalMedicine
Subjects:
Iron deficiency
Anaemia
Children
Iron hydroxide adipate tartrate (IHAT)
Iron supplementation
Clinical trial
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537023000305

Similar Items

Similar Items